Literature DB >> 28146140

Tumor and normal thyroid spheroids: from tissues to zebrafish.

Valentina Cirello1,2, Germano Gaudenzi3, Elisa S Grassi4, Carla Colombo5, Leonardo Vicentini6, Stefano Ferrero7,8, Luca Persani4,3, Giovanni Vitale4,3, Laura Fugazzola4,5.   

Abstract

BACKGROUND: Multicellular spheroids represent an interesting experimental model with promising applications in the pre-clinical studies on anticancer drugs. We recently demonstrated that thyroid spheroids recapitulate the features of the original tissues, in either the differentiated and "stem-like" components. Here we were aimed to characterize thyroid spheroids and to investigate in vivo the proangiogenic potential of patient-derived xenografts (PDX) of spheroids obtained from papillary thyroid cancer (PTC) and the matched normal tissues.
METHODS: Spheroids cultures were obtained from 11 PTCs and matched normal tissues and characterized by immunohistochemistry. The expression of p53, involved in the regulation of stem cell homeostasis, was evaluated. The proangiogenic effect of thyroid spheroids was assessed by the injection in zebrafish embryos.
RESULTS: Thyroid spheroids are enriched in stem-like cells, as shown by the positivity for the stem cell marker OCT4, and by the low level of p53 expression. Interestingly, PTCs and normal thyroid tissues have a detectable p53 expression, whereas the derived spheroids are mainly constituted by cells that express p53 at a lower level. Finally, we show that PDXs derived from PTC or normal spheroids stimulate the migration and the growth of sprouting vessels toward the implant into the zebrafish embryos.
CONCLUSIONS: We report the characterization of multicellular spheroids obtained from PTCs and normal thyroid tissues, showing that they are enriched in stem-like cells. Moreover, we established xenografts of spheroids in zebrafish, demonstrating that they stimulate neoangiogenesis. This in vivo model could be considered as a valuable platform to test the effects of anticancer drugs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28146140     DOI: 10.23736/S0391-1977.17.02610-4

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN: 0391-1977            Impact factor:   2.184


  10 in total

Review 1.  Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches.

Authors:  Giacomo Miserocchi; Chiara Spadazzi; Sebastiano Calpona; Francesco De Rosa; Alice Usai; Alessandro De Vita; Chiara Liverani; Claudia Cocchi; Silvia Vanni; Chiara Calabrese; Massimo Bassi; Giovanni De Luca; Giuseppe Meccariello; Toni Ibrahim; Marco Schiavone; Laura Mercatali
Journal:  J Pers Med       Date:  2022-05-24

Review 2.  Non-mammalian models of multiple endocrine neoplasia type 2.

Authors:  Tirtha K Das; Ross L Cagan
Journal:  Endocr Relat Cancer       Date:  2018-02       Impact factor: 5.678

Review 3.  How zebrafish research has helped in understanding thyroid diseases.

Authors:  Federica Marelli; Luca Persani
Journal:  F1000Res       Date:  2017-12-14

Review 4.  Zebrafish in Translational Cancer Research: Insight into Leukemia, Melanoma, Glioma and Endocrine Tumor Biology.

Authors:  Aurora Irene Idilli; Francesca Precazzini; Maria Caterina Mione; Viviana Anelli
Journal:  Genes (Basel)       Date:  2017-09-20       Impact factor: 4.096

Review 5.  Benefits of Zebrafish Xenograft Models in Cancer Research.

Authors:  Xingyu Chen; Yongyun Li; Tengteng Yao; Renbing Jia
Journal:  Front Cell Dev Biol       Date:  2021-02-11

Review 6.  Zebrafish Models of Paediatric Brain Tumours.

Authors:  Faiza Basheer; Poshmaal Dhar; Rasika M Samarasinghe
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

Review 7.  Quo natas, Danio?-Recent Progress in Modeling Cancer in Zebrafish.

Authors:  Stefanie Kirchberger; Caterina Sturtzel; Susana Pascoal; Martin Distel
Journal:  Front Oncol       Date:  2017-08-28       Impact factor: 6.244

Review 8.  Management and potentialities of primary cancer cultures in preclinical and translational studies.

Authors:  Giacomo Miserocchi; Laura Mercatali; Chiara Liverani; Alessandro De Vita; Chiara Spadazzi; Federica Pieri; Alberto Bongiovanni; Federica Recine; Dino Amadori; Toni Ibrahim
Journal:  J Transl Med       Date:  2017-11-07       Impact factor: 5.531

Review 9.  Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.

Authors:  Veronica Veschi; Francesco Verona; Melania Lo Iacono; Caterina D'Accardo; Gaetana Porcelli; Alice Turdo; Miriam Gaggianesi; Stefano Forte; Dario Giuffrida; Lorenzo Memeo; Matilde Todaro
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-25       Impact factor: 5.555

10.  Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model.

Authors:  Silvia Carra; Germano Gaudenzi; Alessandra Dicitore; Davide Saronni; Maria Celeste Cantone; Alice Plebani; Anna Ghilardi; Maria Orietta Borghi; Leo J Hofland; Luca Persani; Giovanni Vitale
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.